CLSI M100 Group Webinar
The Latest in Antimicrobial Susceptibility Testing
Join CLSI for a webinar on the latest updates in Antimicrobial Susceptibility Testing (AST) with the release of CLSI M100 Ed36. This webinar provides current recommendations for AST in diagnostic settings to ensure your laboratory is prepared to:
- Identify which drugs to test.
- Determine that your test results are reliable.
- Confirm testing results that are unusual or uncommon.
Gain insights on implementing new breakpoints and standards into your laboratory practices, including a discussion of key changes in this edition, including:
- The addition of key recommendations for testing aztreonam-avibactam, a new cutting-edge agent for treating infections caused by multi-drug resistant Enterobacterales.
- Expanded guidance for testing several agents against Acinetobacter spp., including multi-drug-resistant isolates.
- Updated multifacility antibiogram for anaerobic bacteria. This resource remains a valuable tool for understanding the susceptibility trends of anaerobic species.
This registration covers a group of up to 10 participants. You will need to submit the name and email address of each individual receiving P.A.C.E. credits by March 11, 2026. Each participant will need a CLSI user account. Individuals without an account can create one here. For groups larger than 10, contact customerservice@clsi.org.
Registering for a single attendee? Use the individual webinar registration.
{{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceLearning Objectives
Upon completion of this session, participants will be able to:
- Identify the major changes found in the updated 36th edition of the CLSI M100 document.
- Design a strategy for implementing the new standard into laboratory practices.
- Develop a communication strategy for informing clinical personnel of significant AST and reporting changes.
Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program.
Learning Objectives
Upon completion of this session, participants will be able to:
- Identify the major changes found in the updated 36th edition of the CLSI M100 document.
- Design a strategy for implementing the new standard into laboratory practices.
- Develop a communication strategy for informing clinical personnel of significant AST and reporting changes.
Intermediate: Refresher course. Some basic knowledge required, for the experienced staff technologist with some years of experience.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E® Program.